Cite
Thomson AW, Carroll PB, McCauley J, et al. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol. 1993;14(4):323-44doi: 10.1007/BF00192307.
Thomson, A. W., Carroll, P. B., McCauley, J., Woo, J., Abu-Elmagd, K., Starzl, T. E., & Van Thiel, D. H. (1993). FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer seminars in immunopathology, 14(4), 323-44. https://doi.org/10.1007/BF00192307
Thomson, A W, et al. "FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh." Springer seminars in immunopathology vol. 14,4 (1993): 323-44. doi: https://doi.org/10.1007/BF00192307
Thomson AW, Carroll PB, McCauley J, Woo J, Abu-Elmagd K, Starzl TE, Van Thiel DH. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol. 1993;14(4):323-44. doi: 10.1007/BF00192307. PMID: 7686690; PMCID: PMC2966151.
Copy
Download .nbib